Common Equity: The sum of all common equity items.
Firefly Neuroscience, Inc. (AIFF) had Common Equity of $8.44M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.48M |
|
$-2.09M |
|
$0.26M |
|
$0.22M |
|
$2.50M |
|
$-2.01M |
|
$0.01M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.01M |
|
$-1.97M |
|
16.23M |
|
16.23M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$4.46M |
|
$0.20M |
|
$6.45M |
|
$10.91M |
|
$2.45M |
|
-- |
|
$0.01M |
|
$2.47M |
|
|
Common Equity |
$8.44M |
$2.44M |
|
$8.44M |
|
14.87M |
|
| Cash Flow Statement Financials | |
$-1.95M |
|
$-0.06M |
|
$2.39M |
|
$2.75M |
|
$3.13M |
|
$0.38M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
45.57% |
|
-414.43% |
|
-414.43% |
|
-- |
|
-413.20% |
|
-431.75% |
|
$-2.01M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
2.56 |
|
2.51 |
|
35.81 |
|
-23.74% |
|
-82.00% |
|
-18.37% |
|
-23.74% |
|
$0.57 |
|
$-0.12 |
|
$-0.12 |
|